Correlation Between FibroGen and IShares Trust

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroGen and IShares Trust at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and IShares Trust into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroGen and iShares Trust , you can compare the effects of market volatilities on FibroGen and IShares Trust and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of IShares Trust. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and IShares Trust.

Diversification Opportunities for FibroGen and IShares Trust

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between FibroGen and IShares is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and iShares Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Trust and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with IShares Trust. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Trust has no effect on the direction of FibroGen i.e., FibroGen and IShares Trust go up and down completely randomly.

Pair Corralation between FibroGen and IShares Trust

Assuming the 90 days trading horizon FibroGen is expected to generate 3.32 times more return on investment than IShares Trust. However, FibroGen is 3.32 times more volatile than iShares Trust . It trades about 0.03 of its potential returns per unit of risk. iShares Trust is currently generating about -0.04 per unit of risk. If you would invest  770.00  in FibroGen on September 2, 2024 and sell it today you would earn a total of  20.00  from holding FibroGen or generate 2.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

FibroGen  vs.  iShares Trust

 Performance 
       Timeline  
FibroGen 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, FibroGen may actually be approaching a critical reversion point that can send shares even higher in January 2025.
iShares Trust 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Trust has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward-looking indicators, IShares Trust is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

FibroGen and IShares Trust Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroGen and IShares Trust

The main advantage of trading using opposite FibroGen and IShares Trust positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, IShares Trust can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Trust will offset losses from the drop in IShares Trust's long position.
The idea behind FibroGen and iShares Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes